Affiliation:
1. Department of Pharmaceutical Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo
(USP), Ribeirão Preto, São Paulo, Brazil
Abstract
Aims:
Older people, due to the development of multiple morbidities and in a situation of
polypharmacy, become fragile in addition to their own physical and organic aging. For different reasons regarding the treatment, the health care provided, or the physical and mental condition of older
people, problems of adherence to pharmacotherapy are present. Pharmaceutical care is an important
practice to ensure rational pharmacotherapy for this population. The present study aims to describe the
report of pharmacotherapeutic follow-up to a hospitalized older individual with multimorbidity and
use of polypharmacy and to highlight an intervention aimed at adherence to pharmacotherapy.
Case presentation:
This is the planning of a strategy, aimed at promoting health education, which was
carried out during the hospital stay of an older person who was included in the institution's pharmaceutical care services. In addition, at hospital discharge, in order to ensure greater benefits, a bag was
made for the correct storage of medicines and a descriptive didactic list on how to use them. In this
way, improvements were achieved in the transition of care for this patient.
Conclusion:
The importance of developing techniques that promote adherence to pharmacotherapy,
especially for fragile populations, such as older people with multiple diseases, and using polypharmacy is suggested. Individualized educational interventions are instructive measures that can contribute
to people's autonomy in their self-care.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference15 articles.
1. World Health Organization. Decade of healthy ageing: Baseline
report. Geneva: WHO 2020
2. World Health Organization. Medication safety in polypharmacy:
Technical report. Geneva: WHO 2019
3. Yach D.; Hawkes C.; Gould C.L.; Hofman K.J.; The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA 2004,291(21),2616-2622
4. Mills K.T.; Bundy J.D.; Kelly T.N.; Global disparities of hypertension prevalence and control. Circulation 2016,134(6),441-450
5. Cipolle R.J.; Strand L.M.; Morley P.C.; Pharmaceutical care practice: The clinician’s guide 2004